Zacks Investment Research on MSN
4 biotech stocks with major second-half pipeline catalysts this year
The pharmaceutical sector differs from many industries as stock performance often depends less on near-term results and more on the success of products in development. For biotech companies, clinical ...
Portfolio and Holdings List gives you quick overviews and comparisons to analyze multiple investments with ease. Dive deep into your portfolios with Key Metrics to monitor dividend payments, asset & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results